Postpartum Hemorrhage (PPH) Devices Market :Business Overview 2022

Posted by Sandeep Salunkhe on April 11th, 2019

A new report published by Allied Market Research projects that the world post-partum hemorrhage devices market was worth 7 million in 2015 and is expected to reach 6 million by 2022 growing at a CAGR of 5.2% from 2016 to 2022. The Uterine balloon tamponade is expected to remain the highest revenue-generating segment throughout the forecast period.

The factors that are expected to drive the growth of the PPH market are: increasing incidence of pregnancy-related complications, such as multiple pregnancies, inverted uterus, and large baby size; increasing risk factors which cause PPH, such as uterine atony, trauma, retained placenta, and bleeding disorders; and technological advancements in the recently approved devices. However, the lack of trained professionals and healthcare services in developing countries hamper the market growth.

Download Sample @ https://www.alliedmarketresearch.com/request-sample/1676

According to Deepa Tatkare, Analyst, Healthcare Research at AMR, "Amongst the PPH devices, Uterine balloon tamponade segment accounted for almost half of the overall market in 2015 and it is also poised to grow at the highest CAGR of 6.1% from 2016 to 2022." "This is primarily due to the growing number of PPH cases as well as large number of product approvals and increasing positive clinical outcomes of the treatment devices." She further added.

In Uterine balloon tamponade segment, Foley Catheter is projected to grow fastest with a CAGR of 7.8%, as they are cost effective devices. On the other hand, Bakri balloon tamponade is expected to be the highest revenue generating segment in the PPH devices as they can be easily used in low resource settings and is effective in stopping hemorrhage.

Uterine balloon tamponade accounted for a major share in the world PPH devices in 2015, and is expected to maintain this trend throughout the forecast period. This is attributed to the rise in the prevalence of PPH cases, increasing awareness among women regarding postpartum hemorrhage and presence of advanced healthcare facilities in developed countries. However, Asia-Pacific is expected to be the fastest growing region throughout the analysis period, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of PPH cases and high rate of anemia among pregnant women in the region.

Key findings:

• In 2015, Uterine balloon tamponade was the highest revenue-generating segment, and is projected to grow at a CAGR of 6.1% during the forecast period.
• In the uterine balloon tamponade devices, Foley catheter is projected to be the fastest growing segment, registering a CAGR of 7.8% from 2016 to 2022.
• Asia-Pacific is expected to be the fastest growing region in PPH market by 2022 and is projected to grow at a CAGR of 7.6%
• Germany and France accounted for about one-third share of the Europe PPH devices market in 2015.
• In 2015, North America was the highest revenue generating region accounting for one-third of the overall market.

 Send Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/1676